Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bevacizumab (avastin) (1 trial)
panobinostat (farydak) (1 trial)
tpi-287 (1 trial)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Trials (2 total)
Trial APIs (3 total)